501 Santa Monica Boulevard
Suite 700
Santa Monica, CA 90401

Phone: 310-432-4090
Fax: 310-432-4098
www.corcell.com

Cord Blood America, Inc., through its subsidiaries, provides private cord blood stem cell preservation services to families. The company also focuses on collecting, processing and preserving peripheral blood and adipose tissue stem cells allowing individuals to privately preserve their stem cells for potential future use in stem cell therapy. In addition it creates direct response television and radio advertising campaigns, including media placement and commercial production. Subsidiaries The company’s subsidiaries include Cord Partners, CorCell Co. Inc., CorCell Ltd., (Cord), CBA Professional Services, Inc. D/B/A BodyCells, Inc. (BodyCells), CBA Properties, Inc. (Properties), and Career Channel Inc, D/B/A Rainmakers International (Rain). CORD Services Provided By Cord Cord’s customers are typically expectant parents who choose to collect and store umbilical cord blood at the birth of their child for potential use in a stem cell transplant at a later date for that child or for another family member. Through partnering with Progenitor Cell Therapy, LLC (PCT), Cord is able to provide services to collect, test, process and preserve umbilical cord blood. Collection: The company provides a kit that contains all of the materials necessary for collecting the newborn’s umbilical cord blood at birth and packaging the unit for transportation. The kit also provides for collecting a maternal blood sample for later testing. Full-Time Physician and Customer Support: The company provides 24-hour consulting services to customers, as well as to physicians and labor and delivery personnel, providing any instruction necessary on the collection of the cord blood. Transportation: The company manages all logistics for transporting the cord blood unit to its centralized facility immediately following birth. Comprehensive Testing: At the laboratory, the cord blood sample is tested for stem cell concentration levels and blood type. The cord blood sample and the maternal blood sample are also tested for infectious diseases. The company reports these results to both the mother and her doctor. Cord Blood Preservation: After processing and testing, the cord blood unit is cryogenically frozen in a controlled manner and stored in liquid nitrogen for potential future use. The company’s cord blood units are tested, processed and stored at, Progenitor Cell Therapy, LLC (PCT), in Hackensack, New Jersey. BodyCells is a developmental stage company in the business of collecting, processing and preserving peripheral blood and adipose tissue stem cells that allows individuals to privately preserve their stem cells for potential future use in stem cell therapy. RAIN Rain operates in the business of advertising. Rain offers its advertising and direct marketing customers a range of services, including the placement of advertising in television and radio outlets; the production of advertising content, including television commercials, and radio copy; and advertising and marketing consulting services relating to the customer’s marketing campaign. In performing its advertising agency services, Rain outsources commercial production services to third party production companies. Rain’s advertising clients are typically small companies for whom its range of services include, in addition to the placement of advertising, a range of consulting services which can include assistance in program, but helping the client to design or develop the particular product or service, determine the appropriate market and design and implement an overall marketing program and strategy. Significant Events The company has signed an agreement with a marketing affiliate for expansion of its services into Panama, Bermuda and Aruba. The marketing arrangement is intended to target hospitals and obstetricians/gynecologists in those areas. Competition The company’s competitors include Integrated Media, Last Second Media, Media Associates, RevShare, Mercury Media, ChoicePoint Precision Marketing, and E&M Advertising. History Cord Blood America, Inc. was founded in 2003.

Why this is a hot stock

- New Corporate headquarters and cryogenic research and storage laboratory in Las Vegas will open the first week of October 2009. “We anticipate processing of stem cells in the new lab to commence sometime in the fourth quarter of 2009. We are confident that this new facility will assist Cord Blood America to become a giant in the cryogenic storage sector,” said Mr. Schissler.

- The new facility will significantly reduce the cost of sales while increasing gross profits, because we no longer have to outsource the storage and because of its proximity to one of the nation’s busiest airports.

- Company reduced its debt by a total of $3.7 million in the third quarter of 2009. Total debt eliminated in 2009 is $8.7 million.